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PublicAbstract This study aims to examine general public knowledge and behavior toward pharmaceu-
tical advertisements in the Western part of KSA. A cross sectional convenience sampling technique
was used in this study. A total of 1445 valid questionnaires were received and analyzed using SPSS
version 16 at alpha value of 0.05. Majority of respondents were aware of different types of drugs to
be advertised and drug advertisements should seek approval from the health authorities. Television
and Internet showed the highest effect on consumers. Almost half of the participants preferred an
advertised drug over non-advertised one. Most of the respondents indicated that the quality of fre-
quently advertised drugs is not better than those prescribed by the doctors. Majority of participants
had positive beliefs toward advertised drugs concerning their role in education and spreading of
awareness among the public. Pharmaceutical advertisements harm the doctor–patient relationship
as evidenced by one-third of the investigated sample. Moreover, majority of the participants men-
tioned that they would consult another doctor or even change the current doctor if he/she refused to
prescribe an advertised medication. Results of this study could be used to develop awareness pro-
grams for the general public and try to enforce the regulations and policies to protect the general
public and patients from the business oriented pharmaceutical companies and drug suppliers.
ª 2013 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
Pharmaceutical companies have been spending a great percent
of sales on pharmaceutical advertising (Osinga et al., 2010;
McFadden et al., 2007). General public, who are believed to
have a major inﬂuence on prescribing decisions, were targeted
from most pharmaceutical companies.
Direct-to-consumer advertising (DTCA) is banned in most
developed countries, except the USA and New Zealand
(Hanna Toiviainen et al., 2004; Elizabeth et al., 2006).
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duct for Prescription (Ethical) Products (Pharmaceutical Asso-
ciation of Malaysia, 2008). Under this guideline, only medical
professionals can receive promotional material for prescription
drugs. Pharmaceutical companies are not permitted to adver-
tise prescription products directly to the public. In reality,
pharmaceutical industries try to reach the general public
whether directly or indirectly.
Pharmaceutical companies spend large amounts of their
sales dollars on promotions for two reasons; to inform and
persuade (Dev et al., 1993). For many doctors, especially those
who have been practicing medicine for a long time reported
that drug promotions are major sources of new drug informa-
tion which play a major role in their decision making (Vancelik
et al., 2007; Katia et al., 2005; Ahmad et al., 2011). However, it
should be noted that promotion efforts are not only conﬁned
to the prescribers, but also to the public.
General public get their information about medicines from
many sources, such as television (TV), internet, magazines,
health professionals, radio, and newspapers (Na¨rhi and
Helakorpi, 2007). Therefore, inﬂuencing general public
through these Media might affect prescribing and dispensing
decisions. General public might have different responses to
pharmaceutical advertisements. These responses varied from
one person to another according to their knowledge and per-
ceptions toward pharmaceutical advertisements.
To the best of our knowledge, no studies were planned and
implemented to observe public knowledge, perceptions and
practice in response to the pharmaceutical advertisements.
Hence, this study aimed to evaluate the general public knowl-
edge and perceptions toward pharmaceutical advertisements as
well as to evaluate the impact of pharmaceutical advertise-
ments on the decisions made by the general public regarding
medication selection. Expected outcomes of this study could
be utilized by healthcare decision makers for developing
awareness programs and development of policies for regulat-
ing pharmaceutical promotion in the Kingdom of Saudi
Arabia.
2. Methodology
2.1. Study design
A cross-sectional study design was carried out in the Western
region of Saudi Arabia which included Taif, Makkah and Jed-
dah. One thousand and ﬁve hundred Questionnaires were dis-
tributed to the general public using the non probability
convenience sampling technique.
2.2. Data collection tool: The questionnaire
The questionnaire was developed after an extensive literature
review on the current issue. Face and content validation were
done by a group of experts from the Clinical Pharmacy
Department at the Taif University. Questionnaire was divided
into six sections. The ﬁrst section consisted of seven demo-
graphic questions: gender, age, nationality, marital status, edu-
cational level, location of work and residence. The second
section comprised of six questions to explore respondents’
knowledge about pharmaceutical advertisement. The third sec-
tion included questions to explore the impact of different toolsused for pharmaceutical advertisements. Section four included
18 questions to measure respondents’ perceptions toward
pharmaceutical advertisements. Section ﬁve contained a ques-
tion regarding the type of information that respondents usu-
ally look for. The last section investigated the impact of
pharmaceutical advertisements on respondents’ drug selection.
Questionnaire was ﬁrst prepared in English language and then
translated into Arabic Language. The translated Arabic ver-
sion of the questionnaire was then validated by experts from
the Clinical Pharmacy Department at the Taif University
and then tested on 20 respondents to get their feedback and
make any modiﬁcations on the questionnaire. Respondents’
feedback was considered in the ﬁnal version of the question-
naire which was used in this study.
2.3. Inclusion and exclusion criteria
Respondents of this study met the following three criteria: (1)
they were 16 years old and above, (2) able to read and write in
Arabic, and (3) agreed to give a verbal informed consent.
Whereas those below the age of 16 years, unable to read or
write in Arabic or refused to give the informed consent were
excluded from this study.
2.4. Data collection technique
Data collectors met with the respondents in a range of public
areas, such as restaurants, shopping malls, bus stations and
hospitals. First, data collectors introduced themselves to the
respondents and briefed them about the study. Then, they in-
formed them that all data will be kept conﬁdential and their
participation in the study will be voluntary. Once the respon-
dents gave their verbal consent to participate in the study, data
collectors passed them the questionnaire which needed 10–
15 min for completion.
2.5. Statistical analysis
Data obtained from this survey were coded, entered and then
analyzed using the Statistical Package for Social Sciences
(SPSS) Version 16. Descriptive results were presented as fre-
quencies and percentages whereas the Chi-square and Fisher
Exact tests were used to determine the association between
the general public demographic proﬁles and their perceptions
about medicines. P-value <0.05 was considered signiﬁcant.3. Results
Table 1 shows the demographics of the respondents. A total of
1445 respondents successfully responded to this study. Major-
ity of them were males and Saudi nationals with the age group
between 20 and 29 years.
Table 2 summarizes respondents’ understandings toward
pharmaceutical advertising. Majority of respondents were
aware that only drugs without side effects are allowed to be
advertised (57%), medical advertisements should seek govern-
ment approval (73.4%), and only registered drugs are allowed
to be advertised (52.8%). In addition, 50% of respondents said
that direct advertising of OTC products to the public is al-
lowed whereas 41% said that direct advertising of prescribed
Table 1 General characteristics of the respondents.
Demographic characteristics Frequencies (n) Percentages (%)
Gender Male 1402 97.0
Female 44 3.0
Age 620 409 28.3
20–29 602 41.6
30–39 180 12.4
P40 255 17.6
Nationality Saudi 1412 97.6
Non Saudi 34 2.4
Education level Informal education 5 0.3
Primary school 45 3.1
Secondary school 122 8.4
Tertiary school 1274 88.1
Marital status Single 1007 69.6
Married 424 29.3
Widowed/Divorced 15 1.0
City name Jeddah 236 16.3
Makkah 274 18.9
Taif 936 64.7
Residence location Rural 1364 94.3
Urban 82 5.7
Working Health related 638 44.1
Non health related 808 55.9
Any family members job is health related? Yes 592 40.9
No 854 59.1
General public knowledge, perceptions and practice towards pharmaceutical drug advertisements 121drugs to the public is allowed. City of living, age, marital status
and educational level showed signiﬁcant variations among
responses.
The inﬂuence of advertisements on different media is shown
in Table 3. Television and internet have the highest inﬂuence
on our respondents (63.8% and 56.2%, respectively). Adver-
tisements on radio and leaﬂets showed the lowest inﬂuence
on our respondents (38.0% and 38.3%, respectively). City of
living, age, marital status and educational level showed signif-
icant variations (p< 0.05) among responses. A higher propor-
tion of Makkah residents showed good inﬂuence of
advertisements on television, health related magazines and
internet. Whereas, a higher percentage of respondents showed
an average inﬂuence of advertisements on radio, health related
magazines and internet. Television and health related maga-
zines showed an excellent inﬂuence on respondents with a fam-
ily member working in a health related job. A higher
proportion of married respondents showed a neutral inﬂuence
of advertisements on radio, health related magazines, pam-
phlets, friends and family members. On the other hand, a high-
er percentage of respondents without formal education showed
an excellent inﬂuence of advertisements on television and
radio.
Table 4 entails respondents’ perceptions regarding pharma-
ceutical advertisements. Almost half of our respondents (46%)
believed that advertised drugs are better than non-advertised
drugs. Whereas only 58% of the respondents disagreed that
the quality of the frequently advertised products to be better
than those prescribed by healthcare professionals. In addition,
more than half of the respondents (54%) believed that phar-maceutical advertisements make the drugs look better than
their reality. Moreover, only 44% of our respondents believed
that pharmaceutical advertisements provide reliable informa-
tion about the advertised products. On the other hand, 52%
of the respondents believed that pharmaceutical advertise-
ments provide information to educate them about their medi-
cal conditions and help them to have better dialog with their
doctors about their health conditions (60%). City of living,
age, marital status and educational level showed signiﬁcant
variations among responses.
Table 5 summarizes the type of information that the
respondents are interested from any pharmaceutical advertise-
ment. Side effects and uses of the medication were the main
things that the investigated sample is looking for once they
read a pharmaceutical advertisement (67.6% and 42.6%,
respectively). Whereas ease of use was the last thing respon-
dents were interested to read from the advertisement
(10.3%). City of living, age, marital status and level of educa-
tion showed considerable differences among responses. A
higher proportion of Makkah residents, those with more than
40 years of age, and without health related family member, an-
swered no to the statements in Table 5.
Table 6 shows the inﬂuence of pharmaceutical advertise-
ments on respondents’ decisions in drug selection. Drug adver-
tisements showed a median effect on the selection of
respondents to their drugs. Around one-third of the respon-
dents (31.6%) would recommend advertised drugs to their
friends and family members. In addition, almost 35% of
respondents will request their doctor to prescribe them an
advertised drug and more than 60% of respondents said that
Table 2 Respondents’ understandings to pharmaceutical a ertising.
Section Responses Chi-square test exact p-values
(n) (%) (p< 0.05)
Yes No Not sure City Age Work Marital
status
Education
level
Residence
location
Gender
Only drugs without any side
eﬀects are allowed to be
advertised to the public
832 (57.9) 398 ( .7) 208 (14.5) <0.001 <0.001 <0.001 <0.001* <0.001* 0.165 0.771
Medical advertisements should
seek government approval
1059 (73.4) 284 ( .7) 100 (6.9) <0.001 <0.001 <0.001 <0.001* <0.001* 0.453 0.060*
Only registered drugs are allowed
to be advertised
759 (52.8) 503( .0) 175(12.2) <0.001 <0.001 <0.001 <0.001* <0.001* 0.326 0.040
Direct advertising of prescribed
drugs to the public is permitted
586 (41.0) 595 ( .6) 248(17.4) <0.001 <0.001 <0.001 <0.001* <0.001* 0.113 0.218
Direct advertising of over the
counter products (non prescribed
drugs) to the public is permitted
714 (49.9) 524 ( .6) 192 (13.4) <0.001 <0.001 <0.001 <0.001* <0.001* 0.007 0.029
Only safe medicines are allowed
to be advertised to the public
953 (66.5) 281 ( .6) 200 (13.9) <0.001 <0.001 <0.001 <0.001* <0.001* 0.037 0.011
* Fisher Exact test.
Table 3 Inﬂuence level of pharmaceutical advertisements consumers.
Questions Responses Chi-square test exact p-values
E (n)% G ( % A (n) % P (n) % VP (n) % City Age Work Marital
status
Education
level
Residence
location
Gender
Advertisement on television 475(33) 443 0.8) 295 (20.5) 163 (11.3) 63 (4.4) <0.001 <0.001 <0.001 <0.001* <0.001* 0.088* <0.001*
Advertisement on radio 107(7.5) 337 3.5) 446 (31.1) 341 (23.7) 205 (14.3) <0.001 <0.001 0.012 0.005* 0.004* 0.163 <0.001*
Advertisement on health related magazines 343(24) 419 9.4) 393 (27.5) 188 (13.2) 84 (5.9) <0.001 0.001 <0.001 0.001* 0.133* 0.003* <0.001*
Advertisement on newspapers 245(17.2) 449 1.5) 429 (30.1) 224 (15.7) 79 (5.5) 0.008 0.175 0.002 0.730* 0.280* 0.051* 0.101*
Advertisement on internet 346(24) 478 3.2) 388 (27) 153 (10.6) 74 (5.1) <0.001 0.002 <0.001 0.002* 0.058* 0.620* 0.001*
Pamphlets/leaﬂets 142(9.9) 297 0.7) 445 (31.1) 377 (26.3) 172 (12.0) 0.036 0.115 <0.001 0.339* 0.031* 0.218 0.077*
Friends and family members 246(17.2) 410 8.7) 514 (36.0) 198 (13.9) 61 (4.3) <0.001 <0.001 <0.001 <0.001* 0.039* 0.085* <0.001*
Note: E: excellent, G: good, A: average, AP: poor, VP: very p r.
* Fisher Exact test.
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Table 4 Public perceptions on pharmaceutical advertisements.
Questions Responses Chi-square test exact p-values
SD (n) % DA (n) % N (n) % A (n) % SA (n) % City Age Work Marital
status
Education
level
Residence
location
Promoted drugs are better than non-advertised drugs 89 (6.2) 223 (15.6) 451 (31.6) 486 (34) 180 (12.6) <0.001 <0.001 <0.001 <0.001* <0.001* 0.009
Pharmaceutical advertising encourage patients to decide on their
choice of drug without the help of a healthcare professional
(physician, pharmacist, etc.)
186 (13) 359 (25.1) 388 (27.1) 400 (28.0) 97 (6.8) <0.001 <0.001 <0.001 <0.001* <0.001* 0.331
Pharmaceutical advertising provide reliable information regarding
a particular medicine
53 (3.7) 188 (13.2) 548 (38.5) 478 (33.6) 157 (11.0) <0.001 <0.001 <0.001 0.028* 0.005* 0.232*
Pharmaceutical advertising inform patients of potential side eﬀects 93 (6.6) 220 (15.5) 386 (27.2) 509 (35.9) 210 (14.8) <0.001 <0.001 <0.001 0.019* <0.001* 0.076
Pharmaceutical promotions better inform patients of their medical
problem
51 (3.6) 206 (14.5) 429 (30.1) 541 (38.0) 198 (13.9) <0.001 0.002 <0.001 <0.001* 0.002* 0.332
The quality of a particular product depends on the frequency of the
advertising activities
223 (15.7) 383 (26.9) 308 (21.6) 384 (27) 125 (8.8) <0.001 <0.001 <0.001 <0.001* <0.001* 0.137
Pharmaceutical advertising increase drug cost 39 (2.8) 130 (9.2) 479 (33.9) 549 (38.9) 216 (15.3) <0.001 <0.001 <0.001 <0.001* <0.001* 0.366*
Advertisements of pharmaceutical drugs help me have better
discussions with my doctor about my health
18 (1.3) 104 (7.3) 438 (30.9) 645 (45.5) 214 (15.1) <0.001 0.005* <0.001 <0.001* 0.001* 0.714*
I like pharmaceutical advertisements 57 (4) 111 (7.9) 437 (30.9) 587 (41.5) 222 (15.7) <0.001 <0.001 <0.001 <0.001* <0.001* 0.261*
Pharmaceutical advertisements help me make better decisions
about my health
72 (5.1) 162 (11.4) 472 (33.2) 537 (37.8) 179 (12.6) <0.001 <0.001 <0.001 <0.001* <0.001* 0.770*
Pharmaceutical advertisements help make me aware of new drugs 19 (1.4) 80 (5.7) 382 (27.2) 634 (45.2) 288 (20.5) <0.001* 0.021* <0.001 0.010* 0.655* 0.544*
I trust the quality of the frequently advertised drugs more than
those prescribed by healthcare professionals
313 (22) 522 (36.7) 339 (23.8) 164 (11.5) 86 (6) <0.001 <0.001 <0.001 0.010* 0.001* 0.776*
Advertisements of pharmaceutical drugs do not give enough
information about the possible risks and negative eﬀects of using a
drug
70 (4.9) 116 (8.1) 380 (26.6) 49 4 (34.6) 366 (25.7) <0.001 <0.001 <0.001 <0.001* <0.001* 0.046*
Advertisements of pharmaceutical drugs do not give enough
information about the possible beneﬁts and positive eﬀects of using
the drug
38 (2.7) 155 (10.9) 385 (27.1) 551 (38.8) 290 (20.4) <0.001 0.006* <0.001 0.013* 0.371* 0.187*
Pharmaceutical advertisements make the drugs look better than
their reality
20 (1.4) 81 (5.7) 552 (39) 483 (34.1) 281 (19.8.) <0.001* <0.001* <0.001 <0.001* <0.001* 0.135*
I support direct to consumer advertising 40 (2.8) 216 (15.4) 533 (37.9) 501 (35.7) 115 (8.2) <0.001 0.002 <0.001 0.004* <0.001* 0.630*
I prefer all drugs to be advertised to the public 46 (3.2) 172 (12.1) 470 (33.2) 520 (36.7) 208 (14.7) <0.001 <0.001 <0.001 0.002* <0.001* 0.059*
I prefer only over the counter drugs to be advertised to the public 56 (4.0) 416 (29.4) 287 (20.3) 434 (30.7) 221 (15.6) <0.001 <0.001 <0.001 <0.001* <0.001* 0.860*
* Fisher Exact test.
Note: SD: strongly disagree, DA: disagree, N: neutral, A: agree, SA: strongly agree.
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Table 5 Type of information that respondents are interested in any medical advertisement.
Section Responses (n) (%) Chi-square test exact p-valu (p< 0.05)
Yes No City Age Work Marital status Education level Residence location Gender
Ease of use 149 (10.3) 1297 (89.7) <0.001 <0.001 <0.001 0.027* 0.115* 0.562 <0.001*
Side eﬀects 979 (67.7) 467 (32.3) <0.001 0.018 <0.001 0.058* <0.001* 0.113 0.088
Drug–drug interactions 347 (24) 1099 (76) <0.001 <0.001 <0.001 0.003* <0.001* 0.021 0.111
Cost 338 (23.4) 1108 (57.4) 0.009 <0.001 0.887 0.351* 0.892* 0.194 <0.001
Cases that the advertised medication is used to treat 616 (42.6) 830 (76.6) 0.026 <0.001 <0.001 0.260* 0.016* 0.257 <0.001
Others 62 (4.3) 1383 (95.7) <0.001 0.002 <0.001 0.219 0.002* 0.776* 0.713*
* Fisher Exact test.
Table 6 Inﬂuence of pharmaceutical advertisements on drug selection by consumers.
Questions Responses Chi-square test exact p-values
SD (n) % DA (n) % N (n) % A (n) % SA (n)% City Age Work Marital
status
Education
level
Residence
location
Gender
I will ask my doctor to prescribe me an advertised medicine 124 (8.9) 363 (26.1) 495 (35.6) 331 (23.8) 77 (5.5) <0.001 <0.0 <0.001 <0.001* <0.001* 0.679* 0.340*
I will consult another doctor if he/she does not prescribe me an
advertised drug that I requested
202 (14.5) 490 (35.3) 382 (27.5) 256 (18.4) 59 (4.2) <0.001 <0.0 <0.001 <0.001* <0.001* <0.001* 0.081*
I will change my doctor to another if he/she does not prescribe me
an advertised drug that I requested
252 (18.2) 587 (42.5) 328 (23.8) 168 (12.2) 46 (3.3) <0.001 <0.0 <0.001 <0.001* <0.001* 0.013* 0.435*
I prefer to buy advertised drugs despite their price 184 (13.3) 499 (36) 425 (30.7) 231 (16.7) 47 (3.4) <0.001 0.0 <0.001 0.002* <0.001* 0.002* 0.094
I will change my current medication to a more frequently
advertised medicine
226 (16.3) 564 (40.8) 370 (26.7) 185 (13.4) 39 (2.8) <0.001 <0.0 <0.001 <0.001* <0.001* <0.001* 0.010*
I will buy pharmaceutical products on sale regardless their
expiration date
398 (28.7) 490 (35.4) 294 (21.2) 158 (11.4) 45 (3.2) <0.001 <0.0 <0.001 <0.001* <0.001* <0.001* 0.451*
I would buy an advertised drug without referring to my doctor 373 (26.9) 678 (48.9) 207 (14.9) 89 (6.4) 39 (2.8) <0.001 <0.0 <0.001 0.004* <0.001* 0.055* <0.001*
I would recommend advertised drugs to my friends and family
members
186 (13.4) 280 (20.2) 483 (34.8) 353 (25.5) 84 (6.1) <0.001 <0.0 <0.001 <0.001* <0.001* 0.091* 0.005*
* Fisher Exact test.
Note: SD: strongly disagree, DA: disagree, N: neutral, A: agree, SA: strongly agree.
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General public knowledge, perceptions and practice towards pharmaceutical drug advertisements 125they will consult another doctor or change their doctor if he/
she does not prescribe them an advertised drug. Furthermore,
more than 57% of respondents indicated that they will change
their current medications to a more frequently advertised drug
and more than three quarters of respondents mentioned that
they will buy a more frequently advertised drug regardless of
its expiration date. Most demographic variables showed signif-
icant variations (p< 0.05). A higher proportion of Jeddah res-
idents, those with more than 40 years of age, with a health
related family member, with secondary and tertiary educa-
tional levels disagreed on the statements in Table 6.
4. Discussion
To the best of our knowledge, this is the ﬁrst report to explore
consumers’ perceptions and behaviors toward drug advertising
in KSA. The investigated sample composed of 1445 respon-
dents; most of them were Saudi nationals (98%), males
(97%) and young (20–29 years old) (70%).
Majority of respondents were aware of drug types to be
advertised. Participants mentioned that drug advertisements
should be approved by health authorities; however, they were
divided with regard to direct promotion of OTC products. The
effect of different media was investigated in this study. Results
indicated that TV and Internet showed the highest effect on
consumers. These ﬁndings are consistent with the ﬁndings of
Liu and Gupta (2011) and Andrew et al. (2004). The research-
ers found that drug promotions on TV had strong impacts on
underserved parts of the population. On the other hand, Bell
et al. found awareness to be higher among the participants,
329 adults living in California, who were exposed extensively
to printed media (Bell et al., 2010). Another study by Huh
and colleagues on the trust of on-line advertisements on pre-
scription drugs, found that majority of respondents do not
trust the information provided on-line on prescription drugs
(Huh et al., 2005).
Investigation of attitudes and behaviors of consumers to-
ward pharmaceutical advertisements was conducted and al-
most half of the sample preferred promoted medication over
non-promoted. Most of the respondents pointed out that the
quality of frequently advertised drugs is not more than those
prescribed by healthcare providers. Results showed that
majority of the participants have positive attitudes toward
drug advertisements concerning their role in education and
spreading awareness. Suh et al. surveyed 350 patients in South
Korea and found that the respondents had positive attitudes
toward DTCA. Patients mentioned that drug advertisements
are essential and they had intention to use the inclusion infor-
mation (Suh et al., 2011). Similar results were reported by
Harrington et al. (2012). The researchers assessed attitudes
of 243 pharmacy students toward DTCA, and showed that
the participants agreed with the statement that DTCA assists
patients to take more active role in treatment options (Har-
rington et al. 2012). In addition, Gernard et al. found that drug
advertisements increased the awareness of antidepressants
among patients with depression (Grenard et al., 2011). Andrew
et al. found different results in India. Most of the surveyed par-
ticipants were unaware about the side-effects of the OTC med-
ications despite the ﬁndings that drug advertisements had a
signiﬁcant impact on the investigated people of all regions
and classes (Andrew et al., 2004).A random telephone survey of 329 adults living in Califor-
nia showed that awareness was affected by many factors,
including the use of prescription drug, exposure to the media,
positive attitudes toward direct-to-consumer promotion,
poorer health, and insurance status (Kaphingst et al., 2004).
Pharmaceutical advertisements harm the doctor–patient
relationship in many aspects. Pharmaceutical advertisements
do not always inform patients about the possible risks of the
advertised products equally as they inform about their beneﬁts
(Cox and Cox, 2010; Shish and Holt, 1999) which might mis-
lead the patient. For example, around one-third of the investi-
gated sample in this study indicated that they would request a
promoted medication from their doctor. This ﬁnding was sup-
ported by those of Bell et al. (2010). Their study showed that
antidepressant promotions resulted in requests for a new drug
or a change in medication. Another support for the negative
effect of drug advertisements was found by Grenard et al.
(2011). Their study indicated that seniors’ request for a pre-
scription as a result of drug promotions may complicate the
relationship between the doctors and their patients. Moreover,
majority of the respondents mentioned that they would consult
another doctor or even change the doctor is conditional with
his/her refusal to prescribe a promoted drug. Bell et al. found
similar results as one third of the sample initiated a dialog
about a promoted drug and 20% had requested a promoted
medication (Bell et al., 2010). Furthermore, a study that eval-
uated the impact of TV advertisement of medication for sea-
sonal allergy of asthma found that about 90% of
respondents have seen the advertisement and 12.4% of them
created a communication with their doctors asking them about
the advertised drug (Khanfar et al., 2008). In contrast to our
ﬁndings, Liu and Gupta showed that DTCA had a positive
and long-range impact on the number of visits to doctors
(Liu and Gupta, 2011). Another study found that patients
who requested speciﬁc drug brands were only 3.5%. In fact,
physicians indicated that patients request had a positive inﬂu-
ence on the doctor–patient relationship (Wilkes et al., 2000).
It is worth not to ignore the confusing effect of some
DTCA, a study conducted by Hyla et al. to measure the impact
of DTCA on patients’ behaviors found that more than one
quarter of their respondents were confused from the advertise-
ments. In addition 17.8% of them stopped taking their medi-
cations due to considerable side effects mentioned in the
advertisement (Hyla et al., 2009).
The present study has limitations. Although the sample size
is large (1445), it cannot be considered representative of the
general population in the Kingdom of Saudi Arabia. For
example, 97% of the investigated sample are males while the
remaining (3%) are females. The low percentage of female
respondents in this study is due to the fact that all data collec-
tors are males in which the Saudi culture does not allow direct
mixing and contact of males with females. Thus, we managed
only to collect data from a very low percentage of female
respondents. Despite the previously mentioned drawbacks,
ﬁndings of this study are worthy of more survey with a larger
and more heterogeneous population.
5. Conclusion
Findings of this study highlighted general public knowledge,
perceptions and practice toward pharmaceutical
126 M.S. Al-Haddad et al.advertisements. A great percentage of participants were
aware of authorized drugs to be advertised. Even though
the frequency of pharmaceutical advertisements was not
perceived to affect the quality of the advertised medication,
rather, majority of respondents preferred to buy a more
frequently advertised medicine. Policy makers have to be
concerned about the impact of pharmaceutical advertise-
ments on the public. Hence, enforcement of the regulations
and laws regarding protecting the public from the proﬁt
oriented organizations is imperative.
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